Life Sciences
The new firm will offer partners an expanded range of methods and workflows for small-molecule and peptide drug discovery.
The funds will be used to improve the company's flight cadence and expand its pharmaceutical lab capabilities.
Proceeds will go to settling debts and focusing on its business in the United States.
The Focalist system aims to combine handheld robotics with real-time imaging to enable clinicians to place needles more precisely.
The company will use the funds for a European feasibility study for its transcatheter device and for the launch of a U.S.-based clinical study.
The spin-off company is expected to rake in almost $2 billion in revenue this year.
The acquisition is expected to boost Teleflex's global footprint in the peripheral intervention market.
The AI-based early warning system the NHS is developing is part of the government's 10 Year Health Plan to use data to identify patient safety concerns.
The sale drew mixed reactions, with some U.S. states supporting it as a privacy measure and others objecting over legal and data concerns.
The alliance merges DarioHealth's cardiometabolic and behavioral AI-powered health offering with GreenKey's system for managing obstructive sleep apnea.